Community/Retail

The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Latest News

Neuromuscular disorders neon glow nervous system visualizing diseases like ALS myasthenia gravis being treated advanced therapies under Neurology
Cemdisiran Monotherapy Improves Activities of Daily Living in Myasthenia Gravis

September 7th 2025

Both cemdisiran alone and combined with pozelimab improved the Myasthenia Gravis Activities of Daily Living score in patients with generalized myasthenia gravis.

Eye scan showing macular degeneration -- Image credit: Rabizo Anatolii | stock.adobe.com
Efficacy, Safety, and Immunogenicity Maintained When Patients With nAMD Switch from Eylea to Biosimilar

September 5th 2025

Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service
Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service

September 5th 2025

FDA approves risperidone extended-release suspension for schizophrenia -- Image credit: wladimir1804 | stock.adobe.com
Amneal’s Injectable Extended-Release Suspension of Risperidone Receives FDA Approval to Treat Schizophrenia

September 4th 2025

White pills in orange bottle with blood glucose meter on blue background with copy space - Image credit: neirfy | stock.adobe.com
Study Finds Greater Risk of Death From Type 2 Diabetes in Patients With Learning Disabilities

September 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.